BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19509545)

  • 1. Molecular genetic analysis of a cell adhesion molecule with homology to L1CAM, contactin 6, and contactin 4 candidate chromosome 3p26pter tumor suppressor genes in ovarian cancer.
    Manderson EN; Birch AH; Shen Z; Mes-Masson AM; Provencher D; Tonin PN
    Int J Gynecol Cancer; 2009 May; 19(4):513-25. PubMed ID: 19509545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.
    Birch AH; Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2008 Jan; 47(1):56-65. PubMed ID: 17620309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2.
    Presneau N; Dewar K; Forgetta V; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2005 Jul; 43(3):141-54. PubMed ID: 15937959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
    Cody NA; Shen Z; Ripeau JS; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
    Mol Carcinog; 2009 Dec; 48(12):1077-92. PubMed ID: 19347865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.
    Presneau N; Mes-Masson AM; Ge B; Provencher D; Hudson TJ; Tonin PN
    Oncogene; 2003 Mar; 22(10):1568-79. PubMed ID: 12629520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.
    Manderson EN; Mes-Masson AM; Novak J; Lee PD; Provencher D; Hudson TJ; Tonin PN
    Genome Res; 2002 Jan; 12(1):112-21. PubMed ID: 11779836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 17q25 genes, RHBDF2 and CYGB, in ovarian cancer.
    Wojnarowicz PM; Provencher DM; Mes-Masson AM; Tonin PN
    Int J Oncol; 2012 Jun; 40(6):1865-80. PubMed ID: 22344671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
    Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
    Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray analysis of gene expression mirrors the biology of an ovarian cancer model.
    Tonin PN; Hudson TJ; Rodier F; Bossolasco M; Lee PD; Novak J; Manderson EN; Provencher D; Mes-Masson AM
    Oncogene; 2001 Oct; 20(45):6617-26. PubMed ID: 11641787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of genetic deletions on chromosome 3 in colorectal cancer: loss of 3p25-pter is associated with distant metastasis and poor survival.
    Tsai MH; Fang WH; Lin SH; Tzeng ST; Huang CS; Yen SJ; Chou SJ; Yang YC
    Ann Surg Oncol; 2011 Sep; 18(9):2662-70. PubMed ID: 21347784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity at chromosome 3p in epithelial ovarian cancer in China.
    Zhang GL; Xu KL
    Int J Gynecol Cancer; 2002; 12(2):198-201. PubMed ID: 11975680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel variant, 1484delG in the 3'UTR of H3F3B, a member of the histone 3B replacement family, in ovarian tumors.
    Presneau N; Shen Z; Provencher D; Mes-Masson AM; Tonin PN
    Int J Oncol; 2005 Jun; 26(6):1621-7. PubMed ID: 15870878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.
    Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2009 Jul; 48(7):648-61. PubMed ID: 19123201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a candidate tumor suppressor gene RHOBTB1 located at a novel allelic loss region 10q21 in head and neck cancer.
    Beder LB; Gunduz M; Ouchida M; Gunduz E; Sakai A; Fukushima K; Nagatsuka H; Ito S; Honjo N; Nishizaki K; Shimizu K
    J Cancer Res Clin Oncol; 2006 Jan; 132(1):19-27. PubMed ID: 16170569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contactin 4 gene locus at 3p26 is a candidate gene of SCA16.
    Miura S; Shibata H; Furuya H; Ohyagi Y; Osoegawa M; Miyoshi Y; Matsunaga H; Shibata A; Matsumoto N; Iwaki A; Taniwaki T; Kikuchi H; Kira J; Fukumaki Y
    Neurology; 2006 Oct; 67(7):1236-41. PubMed ID: 17030759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer.
    Sellar GC; Watt KP; Rabiasz GJ; Stronach EA; Li L; Miller EP; Massie CE; Miller J; Contreras-Moreira B; Scott D; Brown I; Williams AR; Bates PA; Smyth JF; Gabra H
    Nat Genet; 2003 Jul; 34(3):337-43. PubMed ID: 12819783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Molecular Characterization of Two Patients with CNTN6 Copy Number Variations.
    Tassano E; Uccella S; Giacomini T; Severino M; Fiorio P; Gimelli G; Ronchetto P
    Cytogenet Genome Res; 2018; 156(3):144-149. PubMed ID: 30508811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.